Detalhe da pesquisa
1.
Longer term outcomes with single-agent belantamab mafodotin in patients with relapsed or refractory multiple myeloma: 13-month follow-up from the pivotal DREAMM-2 study.
Cancer
; 127(22): 4198-4212, 2021 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-34314018
2.
Achieving accurate compound concentration in cell-based screening: validation of acoustic droplet ejection technology.
J Biomol Screen
; 14(5): 452-9, 2009 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-19498082
3.
Acute pharmacodynamic and antivascular effects of the vascular endothelial growth factor signaling inhibitor AZD2171 in Calu-6 human lung tumor xenografts.
Mol Cancer Ther
; 6(8): 2198-208, 2007 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-17699717